↓ Skip to main content

Dove Medical Press

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma

Overview of attention for article published in Drug Design, Development and Therapy, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
18 Mendeley
Title
Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
Published in
Drug Design, Development and Therapy, March 2015
DOI 10.2147/dddt.s77069
Pubmed ID
Authors

Chongyi Li, Yanli Xiong, Xueqin Yang, Lin’ang Wang, Shiheng Zhang, Nan Dai, Mengxia Li, Tao Ren, Yuxin Yang, Shu-Feng Zhou, Lixia Gan, Dong Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Student > Bachelor 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 6%
Lecturer 1 6%
Other 4 22%
Unknown 4 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 28%
Medicine and Dentistry 4 22%
Agricultural and Biological Sciences 2 11%
Mathematics 1 6%
Immunology and Microbiology 1 6%
Other 1 6%
Unknown 4 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2019.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Drug Design, Development and Therapy
#372
of 2,268 outputs
Outputs of similar age
#62,009
of 270,992 outputs
Outputs of similar age from Drug Design, Development and Therapy
#17
of 70 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,992 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.